Upgrade to SI Premium - Free Trial

Oppenheimer Downgrades The Medicines Company (MDCO) to Perform

November 25, 2019 4:14 AM
Oppenheimer analyst Jay Olson downgraded The Medicines Company (NASDAQ: MDCO) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change Downgrades

Next Articles